The first studies regarding the use of GRPRs for PET/CT imaging and treatment of prostate cancer were based on radiolabelled GRPR-agonists, such as 68Ga-AMBA/177Lu-AMBA. The gene discussed is GRPR; the disease is Familial prostate cancer.